1. Home
  2. DGX vs ALGN Comparison

DGX vs ALGN Comparison

Compare DGX & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGX
  • ALGN
  • Stock Information
  • Founded
  • DGX 1967
  • ALGN 1997
  • Country
  • DGX United States
  • ALGN United States
  • Employees
  • DGX N/A
  • ALGN N/A
  • Industry
  • DGX Medical Specialities
  • ALGN Industrial Specialties
  • Sector
  • DGX Health Care
  • ALGN Health Care
  • Exchange
  • DGX Nasdaq
  • ALGN Nasdaq
  • Market Cap
  • DGX 17.5B
  • ALGN 16.5B
  • IPO Year
  • DGX 1996
  • ALGN N/A
  • Fundamental
  • Price
  • DGX $151.26
  • ALGN $212.69
  • Analyst Decision
  • DGX Buy
  • ALGN Hold
  • Analyst Count
  • DGX 14
  • ALGN 10
  • Target Price
  • DGX $168.14
  • ALGN $268.56
  • AVG Volume (30 Days)
  • DGX 794.0K
  • ALGN 677.8K
  • Earning Date
  • DGX 01-30-2025
  • ALGN 01-29-2025
  • Dividend Yield
  • DGX 1.97%
  • ALGN N/A
  • EPS Growth
  • DGX 11.56
  • ALGN 24.62
  • EPS
  • DGX 7.44
  • ALGN 5.86
  • Revenue
  • DGX $9,539,000,000.00
  • ALGN $3,960,519,000.00
  • Revenue This Year
  • DGX $7.33
  • ALGN $5.72
  • Revenue Next Year
  • DGX $8.70
  • ALGN $6.12
  • P/E Ratio
  • DGX $20.46
  • ALGN $36.27
  • Revenue Growth
  • DGX 2.60
  • ALGN 4.03
  • 52 Week Low
  • DGX $123.04
  • ALGN $196.09
  • 52 Week High
  • DGX $165.32
  • ALGN $335.40
  • Technical
  • Relative Strength Index (RSI)
  • DGX 35.27
  • ALGN 36.43
  • Support Level
  • DGX $152.18
  • ALGN $226.67
  • Resistance Level
  • DGX $156.54
  • ALGN $246.19
  • Average True Range (ATR)
  • DGX 2.85
  • ALGN 7.69
  • MACD
  • DGX -1.09
  • ALGN -1.91
  • Stochastic Oscillator
  • DGX 0.00
  • ALGN 0.56

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: